Article
Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts
8 Apr 2020
Abstract excerpt
Reversing the developmental switch from fetal hemoglobin (HbF, α2γ2) to adult hemoglobin (HbA, α2β2) is an important therapeutic approach in sickle cell disease (SCD) and β-thalassemia. In healthy individuals, SCD patients, and patients treated with pharmacologic HbF inducers, HbF is present only in a subset of red blood cells known as F cells. Despite more than 50 years of observations, the cause for this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
